Dermatomyositis

Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Pinal-Fernandez and Mammen
Olivier Benveniste, Yves Allenbach, Benjamin Granger

Annals of the Rheumatic Diseases Oct 2020, 79 (10) e130; DOI: 10.1136/annrheumdis-2019-216007
Response to ‘Augmented vs. artificial intelligence for stratification of patients with myositis’ by Mahler et al
Alain Meyer, Lionel Spielmann, François Séverac

Annals of the Rheumatic Diseases Dec 2020, 79 (12) e163; DOI: 10.1136/annrheumdis-2019-216014
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis
Naoko Okiyama, Yuki Ichimura, Miwako Shobo, Ryota Tanaka, Noriko Kubota, Akimasa Saito, Yosuke Ishitsuka, Rei Watanabe, Yasuhiro Fujisawa, Yoshiyuki Nakamura, Akihiro Murakami, Hisako Kayama, Kiyoshi Takeda, Manabu Fujimoto

Annals of the Rheumatic Diseases Sep 2021, 80 (9) 1201-1208; DOI: 10.1136/annrheumdis-2020-218661
Detection of myositis-specific antibodies
Jean-Baptiste Vulsteke, Ellen De Langhe, Kristl G Claeys, Doreen Dillaerts, Koen Poesen, Jan Lenaerts, René Westhovens, Philip Van Damme, Daniel Blockmans, Petra De Haes, Xavier Bossuyt

Annals of the Rheumatic Diseases Jan 2019, 78 (1) e7; DOI: 10.1136/annrheumdis-2017-212915
Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis
Hanna Kim, Samantha Dill, Michelle O'Brien, Laura Vian, Xiaobai Li, Manuk Manukyan, Minal Jain, Lilian W Adeojo, Jomy George, Maria Perez, Alexei A Grom, Michelle Sutter, Brian M Feldman, Lawrence Yao, Michelle Millwood, April Brundidge, Dominique C Pichard, Edward W Cowen, Yinghui Shi, Shajia Lu, Wanxia Li Tsai, Massimo Gadina, Lisa G Rider, Robert A Colbert

Annals of the Rheumatic Diseases Mar 2021, 80 (3) 406-408; DOI: 10.1136/annrheumdis-2020-218690
Standardisation of myositis-specific antibodies: where are we today?
Michael Mahler, Jean-Baptiste Vulsteke, Xavier Bossuyt, Ellen De Langhe, Minoru Satoh

Annals of the Rheumatic Diseases Aug 2021, 80 (8) e132; DOI: 10.1136/annrheumdis-2019-216003
Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2
Sheng-Xiao Zhang, Jia Wang, He-Hua Sun, Jia-Qian Zhang, Guang-Ying Liu, Jing Luo, Pei-Feng He, Xiao-Feng Li

Annals of the Rheumatic Diseases Aug 2021, 80 (8) e130; DOI: 10.1136/annrheumdis-2019-216246
Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO’s adverse drug reactions database
Thủy Nguyễn, Alexandre Thibault Jacques Maria, Chayma Ladhari, Pascale Palassin, Xavier Quantin, Candice Lesage, Guillaume Taïeb, Xavier Ayrignac, Patricia Rullier, Dominique Hillaire-Buys, Olivier Lambotte, Philippe Guilpain, Jean-Luc Faillie

Annals of the Rheumatic Diseases Feb 2022, 81 (2) e32; DOI: 10.1136/annrheumdis-2020-217018
Response to: ‘Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis’ by Campochiaro et al
Lionel Spielmann, François Séverac, Alain Meyer

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e114; DOI: 10.1136/annrheumdis-2019-216095
Correspondence on ‘Standardisation of myositis-specific antibodies: where are we today?’
Maria Infantino, Mariangela Manfredi, Nicola Bizzaro

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e115; DOI: 10.1136/annrheumdis-2019-216217

Main menu

Dermatomyositis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dermatomyositis

Pages